STAAR Surgical Company (STAA) Announces Earnings Results

STAAR Surgical Company (NASDAQ:STAA) issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.05) by $0.04, Briefing.com reports. The firm had revenue of $21.90 million for the quarter, compared to analyst estimates of $22.15 million. STAAR Surgical had a negative return on equity of 8.69% and a negative net margin of 6.06%. The business’s revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.02) earnings per share.

STAAR Surgical (NASDAQ STAA) traded up 8.29% during midday trading on Friday, hitting $11.75. The company had a trading volume of 269,882 shares. STAAR Surgical has a 52-week low of $7.45 and a 52-week high of $11.90. The firm’s market cap is $483.02 million. The stock has a 50 day moving average of $10.48 and a 200 day moving average of $9.94.

A number of equities analysts have weighed in on the company. BidaskClub raised STAAR Surgical from a “strong sell” rating to a “sell” rating in a research note on Friday. Zacks Investment Research lowered STAAR Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Finally, Canaccord Genuity reissued a “hold” rating on shares of STAAR Surgical in a research note on Tuesday, July 11th.

Hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in STAAR Surgical by 6.3% in the first quarter. Geode Capital Management LLC now owns 245,080 shares of the medical instruments supplier’s stock valued at $2,401,000 after buying an additional 14,420 shares during the period. Vanguard Group Inc. boosted its stake in STAAR Surgical by 1.5% in the first quarter. Vanguard Group Inc. now owns 1,272,972 shares of the medical instruments supplier’s stock valued at $12,475,000 after buying an additional 18,621 shares during the period. Menta Capital LLC boosted its stake in STAAR Surgical by 25.0% in the first quarter. Menta Capital LLC now owns 185,408 shares of the medical instruments supplier’s stock valued at $1,817,000 after buying an additional 37,134 shares during the period. Teachers Advisors LLC boosted its stake in STAAR Surgical by 3.0% in the first quarter. Teachers Advisors LLC now owns 74,044 shares of the medical instruments supplier’s stock valued at $726,000 after buying an additional 2,162 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in STAAR Surgical by 0.9% in the first quarter. Principal Financial Group Inc. now owns 295,129 shares of the medical instruments supplier’s stock valued at $2,893,000 after buying an additional 2,537 shares during the period. 75.94% of the stock is owned by institutional investors.

WARNING: This article was originally published by BNB Daily and is owned by of BNB Daily. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/14/staar-surgical-company-staa-announces-earnings-results-beats-estimates-by-0-04-eps-updated.html.

STAAR Surgical Company Profile

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Earnings History for STAAR Surgical (NASDAQ:STAA)

Receive News & Ratings for STAAR Surgical Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply